Director Duke Liberty Smith acquires common shares of Callan JMB Inc

Callan Jmb Inc - Appoints Christopher Shields as Interim CFO - SEC Filing

Callan JMB Inc. Sets Interim CFO Base Salary at $230,000 with Bonus Opportunity and Stock Options

Callan JMB Inc. Announces Date for Upcoming Annual Stockholders Meeting

Callan JMB Reports Q3 2025 Results and Expands Logistics Platform

Callan JMB Enters Agreement to Install Oral Drug Delivery Equipment in Texas Facility

Callan JMB Upgrades Sentry Monitoring System Technology with Sentry 4 for Mobile Temperature Monitoring

Callan JMB Announces Participation in the LD Micro Main Event XIX Conference on October 19-21, 2025

Callan JMB Inc. Shareholders Approve Potential Issuance of Over 19.99% New Shares Under Hexstone Capital Agreement

Callan JMB Inc. Approves Potential Issuance of Over 19.99% Common Stock to Hexstone Capital

Callan JMB to Participate in Upcoming September Conferences

BRIEF-Callan Jmb Inc Files For Resale Of 6,000,000 Shares Of Common Stock

Callan Jmb Inc - Files for Resale of 6,000,000 Shares of Common Stock - SEC Filing

Callan Jmb Q2 EPS $(0.31) Down From $(0.04) YoY, Sales $1.666M Down From $1.986M YoY

Callan JMB Inc. Reports Decline in Q2 2025 Revenues to $1.7 Million, Operating Loss of $1.4 Million Amid Decreased Demand for Emergency Preparedness Services

Callan JMB Announces Second Quarter 2025 Financial Results and Provides Business Update

Callan Jmb Inc - on July 24, Enters Agreement to Sell up to $25 Mln in Shares - SEC Filing

Callan JMB Inc. Enters $25 Million Purchase Agreement with Investor for Common Stock Sales

Callan JMB Extends Long-Term Contract with City of Chicago and Receives Increase in Funding